Your browser doesn't support javascript.
loading
Olfactory dysfunction in patients with Wilson's Disease.
Piechal, Agnieszka; Bembenek, Jan; Baranowska, Anna; Litwin, Tomasz; Mirowska-Guzel, Dagmara; Czlonkowska, Anna.
Afiliación
  • Piechal A; Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
  • Bembenek J; Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology, Medical University of Warsaw, Warsaw, Poland.
  • Baranowska A; Department of Clinical Neurophysiology, Institute of Psychiatry and Neurology, Warsaw, Poland. jbembenek@o2.pl.
  • Litwin T; Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
  • Mirowska-Guzel D; Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
  • Czlonkowska A; Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology, Medical University of Warsaw, Warsaw, Poland.
Neurol Neurochir Pol ; 57(2): 212-218, 2023.
Article en En | MEDLINE | ID: mdl-36939310
INTRODUCTION: Many neurodegenerative disorders are associated with olfactory dysfunction (OD), but little is known about OD in Wilson's Disease (WD). We evaluated olfactory function in patients with WD. MATERIAL AND METHODS: OD was examined in 68 patients with WD and 70 sex- and age-matched healthy controls using subjective testing with 'Sniffin Sticks'. Threshold discrimination identification (TDI) score and its three components (odour detection threshold, discrimination, and identification) were assessed. RESULTS: Compared to controls, patients with WD had a significantly weaker sense of smell in terms of TDI (p < 0.01), odour discrimination (p < 0.01), and identification (p < 0.01), but not in terms of odour detection threshold (p = 0.27). Patients with predominantly neurological symptoms were characterised by greater OD by TDI (p < 0.01), odour detection threshold (p = 0.01), and discrimination (p = 0.03). The presence of pathological lesions (p = 0.04) in brain magnetic resonance imaging and generalised brain atrophy (p = 0.02) predisposed to worse TDI. In the WD group, weak inverse correlations between age and TDI score (r = -0.27), odour detection threshold (r = -0.3), and discrimination (r = -0.3) were found. Male gender was a risk factor for abnormal TDI in both WD and controls (both p = 0.02). CONCLUSIONS: Patients with WD, particularly older individuals, more frequently had OD than healthy volunteers. Predominantly neurological symptoms, and the presence of typical brain MRI changes, predisposed patients with WD to smell disorders.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Degeneración Hepatolenticular / Trastornos del Olfato Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Neurol Neurochir Pol Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Polonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Degeneración Hepatolenticular / Trastornos del Olfato Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Neurol Neurochir Pol Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Polonia